N-羟基胞苷

N-羟基胞苷性质、用途与生产工艺

生物活性

EIDD-1931 (Beta-d-N4-hydroxycytidine, β-d-N4-hydroxycytidine, NHC)是EIDD-2801的活性代谢产物，它是一种很有前途的 COVID-19 抑制剂。 EIDD-1931（NHC）对 SARS-CoV-2、MERS-CoV、SARS-CoV 和 related zoonotic group 2b或2c Bat-CoVs，对应的平均IC50值为0.15 μM，并且对带有对核苷类似物抑制剂remdesivir耐药性突变的冠状病毒的效力增强。

体外研究

N-羟基胞苷 上下游产品信息

上游原料

下游产品

N-羟基胞苷 试剂级价格

更新日期	产品编号	产品名称	CAS编号	包装	价格
2024/04/30	HY-125033	N-羟基胞苷 EIDD-1931	3258-02-4	5mg	250元
2024/04/30	HY-125033	N-羟基胞苷 EIDD-1931	3258-02-4	10mg	350元

N-羟基胞苷 生产厂家

 

3258-02-4, N-羟基胞苷 相关搜索:

• 合成有机化合物配体
• 化学试剂
• 原料药
• 精细化工原料
• 对照品
• 杂质对照品
• 原料药及中间体类
• 化工原料
• 化合物产品
• 医药原料
• 抑制剂
• 芳香族
• 328-02-4
• 孟努匹拉韦杂质1
• 1-((2R,3R,4S,5R)-3,4-二羟基-5-(羟甲基)四氢呋喃-2-基)-4-(羟基亚氨基)-3,4-二氢嘧啶-2(1H)-酮 (莫钠皮拉韦杂质)
• 莫那比拉韦杂质B/N-羟基胞苷
• 莫诺拉韦杂质A
• Β-D-N4-HYDROXYCYTIDINE
• N4-羟基胞苷
• 莫那匹韦杂质1
• N-羟基胞苷(NHC(EIDD-1931))
• N-羟基胞苷
• 1-((2R,3R,4S,5R)-3,4-二羟基-5-(羟甲基)四氢呋喃-2-基)-4-(肟基)-3,4-二氢嘧啶-2(1H)-酮
• 莫努匹韦杂质
• 莫努匹韦杂质 1
• EIDD-1931 N-羟基胞苷
• 莫匹拉韦中间体EIDD-1931
• 莫匹拉韦中EIDD-1931
• 莫那比拉韦杂质1
• N-羟基胞苷(NHC)
• 1-((2R,3R,4S,5R)-3,4-二羟基-5-(羟甲基)四氢呋喃-2-基)-4-(羟基亚氨基)-3,4-二氢嘧啶-2(1H)-酮
• 3258-02-4
• EIDD2801-metabolite
• EIDD-2801-metabolite
• EIDD 2801-metabolit
• N4-Hydroxycytidine (NHC)
• Monovir impurity A
• 1-((2R,3R,4S,5R)-3,4-Dihydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl)-4-(hydroxyimino)-3,4-dihydropyrimidin-2(1H)-one (Molnupiravir Impurity)
• 1-[(2R,3R,4S,5R)-3,4-Dihydroxy-5-(Hydroxymethyl)Oxolan-2-Yl]-4-(Hydroxyamino)Pyrimidin-2-One
• Chikungunya,equine,Enterovirus,HEV,EIDD 1931,HRV,Hepatitis C virus,Inhibitor,EIDD1931,CHIKV,Topoisomerase,Enterovirus,VEEV,HEVs,NHC,Rhinovirus,HCV,encephalitis,SARS-CoV,EIDD-1931,inhibit,venezuelan,HRVs,SARS coronavirus
• N-Hydroxycytidine
• EIDD-1931
• N-Hydroxycytidine (EIDD-1931) for cell culture, 98%, Endotoxin (BET) 0.05EU/mg
• 1-((2R,3R,4S,5R)-3,4-Dihydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl)-4-(hydroxyimino)-3,4-dihydropyrimidin-2(1H)-oneQ: What is 1-((2R,3R,4S,5R)-3,4-Dihydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl)-4-(hydroxyimino)-3,4-dihydropyrimidin-2(1H)-one Q: What is the CAS Number of 1-((2R,3R,4S,5R)-3,4-Dihydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl)-4-(hydroxyimino)-3,4-dihydropyrimidin-2(1H)-one Q: What is the storage condition of 1-((2R,3R,4S,5R)-3,4-Dihydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl)-4-(hydroxyimino)-3,4-dihydropyrimidin-2(1H)-one
• EIDD-1931 (Beta-d-N4-hydroxycytidine
• 0/4/58
• Molnupiravir Impurity A/N-hydroxycytidine
• Molnupiravir Impurity 1
• EIDD-193
• EIDD2801 ,β-D-N4-hydroxycytidine
• Uridine, 4-oxime
• Beta-d-N4-hydroxycytidine (NHC)
• Beta-d-N4-hydroxycytidine
• β-D-N4-Hydroxycytidine
• 3,4-Dihydro-1-β-D-ribofuranosyl-4-(hydroxyimino)pyrimidin-2(1H)-one
• 1-[(2R)-3α,4α-Dihydroxy-5β-(hydroxymethyl)oxolane-2β-yl]-4-(hydroxyamino)pyrimidine-2(1H)-one
• N(4)-hydroxycytidine